Skip to main content
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Sexual health
  4. Contraception
  5. Back
  6. Combined hormonal contraception
  7. First prescription, documentation, and follow up
Update your RDS mobile app to v4.7.2 to download toolkits even when website is down.

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.

Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience  arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

First prescription, documentation, and follow up

Documentation

  • The full visit history should be completed / updated on NaSH.
  • Written method information or SMS link/leaflet including information about actions after missed pills, ring or patch and a contact number is given to client.
  • Record prescription on NaSH
  • Nurse supplying where appropriate under patient group direction.
  • Consider notifying GP of prescription, if permission is given for correspondence

First prescription

At first prescription of CHC, all women should be informed that CHC use is safe for the majority but can be associated with rare but serious harms. Discuss the risks as found in Indications, efficacy, side-effects, and risks

 

Follow up

Return visit

  • Women should be encouraged to attend their GP for follow up and ongoing supply of CHC.
  • A 12 month supply (except for NuvaRing) may be issued to clients at the initial visit, and thereafter provided no problems have been identified.
  • Nuvaring must be used within 4 months after dispensing. Clients should therefore only be issued with a 3 month supply at any visit. Even with extended use, no more than one box of 3 rings can be issued at one time.

Editorial Information

Last reviewed: 31/01/2024

Next review date: 31/01/2026

Author(s): West of Scotland Managed Clinical Network for Sexual Health Clinical Guidelines Group.

Version: 9.1

Approved By: West of Scotland Managed Clinical Network for Sexual Health